Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.

Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A.

PLoS Pathog. 2019 Jul 29;15(7):e1007945. doi: 10.1371/journal.ppat.1007945. eCollection 2019 Jul.

2.

Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).

Desnos-Ollivier M, Bretagne S, Boullié A, Gautier C, Dromer F, Lortholary O; French Mycoses Study Group.

Clin Microbiol Infect. 2019 May;25(5):634.e1-634.e4. doi: 10.1016/j.cmi.2019.02.007. Epub 2019 Feb 14.

PMID:
30771532
3.

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.

4.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4. Erratum in: Trials. 2019 Jan 14;20(1):48.

5.

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.

Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS.

Lancet Infect Dis. 2019 Apr;19(4):e143-e147. doi: 10.1016/S1473-3099(18)30493-6. Epub 2018 Oct 18. Review.

PMID:
30344084
6.

Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis.

Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, Dromer F, Harrison T, Cohen JF, Lortholary O.

Clin Infect Dis. 2019 Feb 1;68(4):688-698. doi: 10.1093/cid/ciy567.

7.

Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators.

Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA, Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo CA, Dromer F, Nielsen K, Alanio A.

PLoS Pathog. 2018 May 18;14(5):e1006982. doi: 10.1371/journal.ppat.1006982. eCollection 2018 May.

8.

Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing.

Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A.

MBio. 2018 Apr 24;9(2). pii: e00573-18. doi: 10.1128/mBio.00573-18.

9.

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.

Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O.

Front Microbiol. 2018 Mar 13;9:409. doi: 10.3389/fmicb.2018.00409. eCollection 2018.

10.

Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism.

Desnos-Ollivier M, Bórmida V, Poirier P, Nourrisson C, Pan D, Bretagne S, Puime A, Dromer F; French Mycoses Study Group; Uruguayan Invasive Fungal Infection Network.

Mycopathologia. 2018 Apr;183(2):381-390. doi: 10.1007/s11046-017-0224-7. Epub 2017 Nov 16.

PMID:
29147867
11.

Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.

Cogliati M, Puccianti E, Montagna MT, De Donno A, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Trovato L, Dipineto L, Rickerts V, Akcaglar S, Mlinaric-Missoni E, Bertout S, Vencà ACF, Sampaio AC, Criseo G, Ranque S, Çerikçioğlu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Boekhout T, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Colom MF.

Environ Microbiol. 2017 Oct;19(10):4318-4325. doi: 10.1111/1462-2920.13915. Epub 2017 Sep 15.

PMID:
28892309
12.

Cryptococcal meningitis: A neglected NTD?

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. eCollection 2017 Jun. No abstract available.

13.

Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).

Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F; French Mycosis Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1784-1793. doi: 10.1093/jac/dkx045.

PMID:
28333259
14.

The risk and clinical outcome of candidemia depending on underlying malignancy.

Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F; French Mycoses Study Group.

Intensive Care Med. 2017 May;43(5):652-662. doi: 10.1007/s00134-017-4743-y. Epub 2017 Mar 20.

15.

The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, Bicanic TA, Castañeda E, Chang YC, Chen J, Cogliati M, Dromer F, Ellis D, Filler SG, Fisher MC, Harrison TS, Holland SM, Kohno S, Kronstad JW, Lazera M, Levitz SM, Lionakis MS, May RC, Ngamskulrongroj P, Pappas PG, Perfect JR, Rickerts V, Sorrell TC, Walsh TJ, Williamson PR, Xu J, Zelazny AM, Casadevall A.

mSphere. 2017 Jan 11;2(1). pii: e00357-16. doi: 10.1128/mSphere.00357-16. eCollection 2017 Jan-Feb.

16.

Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins MD, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF.

FEMS Yeast Res. 2016 Nov;16(7). pii: fow086. No abstract available.

17.

Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France.

Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, Lortholary O; French Mycosis Study Group.

Open Forum Infect Dis. 2016 Jun 25;3(2):ofw106. doi: 10.1093/ofid/ofw106. eCollection 2016 Apr.

18.

Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing.

Alanio A, Gits-Muselli M, Mercier-Delarue S, Dromer F, Bretagne S.

Front Microbiol. 2016 May 24;7:733. doi: 10.3389/fmicb.2016.00733. eCollection 2016.

19.

Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins Mda L, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF.

FEMS Yeast Res. 2016 Jun;16(4). pii: fow045. doi: 10.1093/femsyr/fow045. Epub 2016 May 5. Erratum in: FEMS Yeast Res. 2016 Nov;16(7):. Griseo, Giuseppe [corrected to Criseo, Giuseppe].

20.

Absence of Fungal Spore Internalization by Bronchial Epithelium in Mouse Models Evidenced by a New Bioimaging Approach and Transmission Electronic Microscopy.

Rammaert B, Jouvion G, de Chaumont F, Garcia-Hermoso D, Szczepaniak C, Renaudat C, Olivo-Marin JC, Chrétien F, Dromer F, Bretagne S.

Am J Pathol. 2015 Sep;185(9):2421-30. doi: 10.1016/j.ajpath.2015.04.027. Epub 2015 Jul 10.

PMID:
26165863
21.

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.

Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F; French Cryptococcosis Study Group.

MBio. 2015 Jun 9;6(3):e00311. doi: 10.1128/mBio.00311-15.

22.

Cryptococcus neoformans host adaptation: toward biological evidence of dormancy.

Alanio A, Vernel-Pauillac F, Sturny-Leclère A, Dromer F.

MBio. 2015 Mar 31;6(2). pii: e02580-14. doi: 10.1128/mBio.02580-14.

23.

International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database--the quality controlled standard tool for routine identification of human and animal pathogenic fungi.

Irinyi L, Serena C, Garcia-Hermoso D, Arabatzis M, Desnos-Ollivier M, Vu D, Cardinali G, Arthur I, Normand AC, Giraldo A, da Cunha KC, Sandoval-Denis M, Hendrickx M, Nishikaku AS, de Azevedo Melo AS, Merseguel KB, Khan A, Parente Rocha JA, Sampaio P, da Silva Briones MR, e Ferreira RC, de Medeiros Muniz M, Castañón-Olivares LR, Estrada-Barcenas D, Cassagne C, Mary C, Duan SY, Kong F, Sun AY, Zeng X, Zhao Z, Gantois N, Botterel F, Robbertse B, Schoch C, Gams W, Ellis D, Halliday C, Chen S, Sorrell TC, Piarroux R, Colombo AL, Pais C, de Hoog S, Zancopé-Oliveira RM, Taylor ML, Toriello C, de Almeida Soares CM, Delhaes L, Stubbe D, Dromer F, Ranque S, Guarro J, Cano-Lira JF, Robert V, Velegraki A, Meyer W.

Med Mycol. 2015 May;53(4):313-37. doi: 10.1093/mmy/myv008. Epub 2015 Mar 22.

PMID:
25802363
24.

Multicenter outbreak of infections by Saprochaete clavata, an unrecognized opportunistic fungal pathogen.

Vaux S, Criscuolo A, Desnos-Ollivier M, Diancourt L, Tarnaud C, Vandenbogaert M, Brisse S, Coignard B, Dromer F; Geotrichum Investigation Group.

MBio. 2014 Dec 16;5(6). pii: e02309-14. doi: 10.1128/mBio.02309-14.

25.

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010).

Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group.

Intensive Care Med. 2014 Sep;40(9):1303-12. doi: 10.1007/s00134-014-3408-3. Epub 2014 Aug 6.

26.

Population-based analysis of invasive fungal infections, France, 2001-2010.

Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F.

Emerg Infect Dis. 2014 Jul;20(7):1149-55. doi: 10.3201/eid2007.140087.

27.
28.

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.

Loyse A, Dromer F, Day J, Lortholary O, Harrison TS.

J Antimicrob Chemother. 2013 Nov;68(11):2435-44. doi: 10.1093/jac/dkt221. Epub 2013 Jun 20. Review.

29.

Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative data.

Bitar D, Morizot G, Van Cauteren D, Dannaoui E, Lanternier F, Lortholary O, Dromer F.

Rev Epidemiol Sante Publique. 2012 Oct;60(5):383-7. doi: 10.1016/j.respe.2012.03.007. Epub 2012 Sep 26.

PMID:
23020929
30.

Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.

Salas V, Pastor FJ, Calvo E, Sutton D, García-Hermoso D, Mayayo E, Dromer F, Fothergill A, Alvarez E, Guarro J.

Med Mycol. 2012 Oct;50(7):710-5. doi: 10.3109/13693786.2012.673137. Epub 2012 Mar 29.

PMID:
22458251
31.

Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens.

Desnos-Ollivier M, Robert V, Raoux-Barbot D, Groenewald M, Dromer F.

PLoS One. 2012;7(3):e32278. doi: 10.1371/journal.pone.0032278. Epub 2012 Mar 1.

32.

Genetic Diversity and Genomic Plasticity of Cryptococcus neoformans AD Hybrid Strains.

Li W, Averette AF, Desnos-Ollivier M, Ni M, Dromer F, Heitman J.

G3 (Bethesda). 2012 Jan;2(1):83-97. doi: 10.1534/g3.111.001255. Epub 2012 Jan 1.

33.

A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O; French Mycosis Study Group.

Clin Infect Dis. 2012 Feb;54 Suppl 1:S35-43. doi: 10.1093/cid/cir880.

PMID:
22247443
34.

Candida spp. with acquired echinocandin resistance, France, 2004-2010.

Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O; French Mycoses Study Group.

Emerg Infect Dis. 2012 Jan;18(1):86-90. doi: 10.3201/eid1801.110556.

35.

Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras.

Peigne V, Dromer F, Elie C, Lidove O, Lortholary O; French Mycosis Study Group.

Am J Trop Med Hyg. 2011 Nov;85(5):934-41. doi: 10.4269/ajtmh.2011.11-0224.

36.

Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.

Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D; French Mycosis Study Group.

Antimicrob Agents Chemother. 2011 Nov;55(11):5358-61. doi: 10.1128/AAC.00690-11. Epub 2011 Aug 22.

37.

Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans.

Alanio A, Desnos-Ollivier M, Dromer F.

MBio. 2011 Aug 9;2(4). pii: e00158-11. doi: 10.1128/mBio.00158-11. Print 2011.

38.

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, Coignard B, Dromer F, Bretagne S; French Mycosis Study Group.

Clin Microbiol Infect. 2011 Dec;17(12):1882-9. doi: 10.1111/j.1469-0691.2011.03548.x. Epub 2011 Jun 10.

39.

Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment.

Desnos-Ollivier M, Moquet O, Chouaki T, Guérin AM, Dromer F.

J Clin Microbiol. 2011 Jun;49(6):2304-6. doi: 10.1128/JCM.00325-11. Epub 2011 Apr 13.

40.

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.

Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group.

Antimicrob Agents Chemother. 2011 Feb;55(2):532-8. doi: 10.1128/AAC.01128-10. Epub 2010 Nov 15.

41.

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J.

J Clin Microbiol. 2010 Dec;48(12):4410-6. doi: 10.1128/JCM.01646-10. Epub 2010 Oct 6.

42.

Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Clin Infect Dis. 2010 Nov 1;51(9):1062-9. doi: 10.1086/656584.

PMID:
20879857
43.

Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans.

Desnos-Ollivier M, Patel S, Spaulding AR, Charlier C, Garcia-Hermoso D, Nielsen K, Dromer F.

MBio. 2010 May 18;1(1). pii: e00091-10. doi: 10.1128/mBio.00091-10.

44.

Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K.

PLoS Pathog. 2010 Jun 17;6(6):e1000953. doi: 10.1371/journal.ppat.1000953. Erratum in: PLoS Pathog. 2010;6(6). doi: 10.1371/annotation/1b59fd9e-9ac9-4ea8-a083-14c413c80b03.

45.

Cutaneous cryptococcosis in solid organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Med Mycol. 2010 Sep;48(6):785-91. doi: 10.3109/13693780903496617.

PMID:
20100136
46.

Genotyping of Candida albicans using length fragment and high-resolution melting analyses together with minisequencing of a polymorphic microsatellite locus.

Costa JM, Garcia-Hermoso D, Olivi M, Cabaret O, Farrugia C, Lecellier G, Dromer F, Bretagne S.

J Microbiol Methods. 2010 Mar;80(3):306-9. doi: 10.1016/j.mimet.2010.01.002. Epub 2010 Jan 21.

PMID:
20096312
47.

Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N.

Transplantation. 2010 Jan 15;89(1):69-74. doi: 10.1097/TP.0b013e3181bcda41.

48.

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC.

Clin Infect Dis. 2010 Feb 1;50(3):291-322. doi: 10.1086/649858.

49.

Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4.

Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, Arenzana-Seisdedos F, Lortholary O.

Blood. 2010 May 6;115(18):3708-17. doi: 10.1182/blood-2009-02-202796. Epub 2009 Dec 28.

50.

Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France.

Brugière O, Forget E, Biondi G, Métivier AC, Mal H, Dauriat G, Faussart A, Dupont B, Lortholary O, Dromer F.

Transplantation. 2009 Dec 15;88(11):1319-20. doi: 10.1097/TP.0b013e3181bc22e1. No abstract available.

PMID:
19996932

Supplemental Content

Loading ...
Support Center